help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on August 28, 2009, doi:10.1165/rcmb.2009-0220TR
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2009-0220TRv1
41/6/631    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCMB
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Barnes, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, P. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 41, pp. 631-638, 2009
© 2009 American Thoracic Society
DOI: 10.1165/rcmb.2009-0220TR


Red in Translation

The Cytokine Network in Chronic Obstructive Pulmonary Disease

Peter J. Barnes1

1 National Heart and Lung Institute, Imperial College London, London, United Kingdom

Correspondence and requests for reprints should be addressed to Peter J. Barnes, D.M., F.Med.Sci., F.R.S., Airway Disease Section, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK. E-mail: p.j.barnes{at}imperial.ac.uk

Abstract

Multiple cytokines play a role in the orchestration of inflammation in inflammatory airway diseases, such as chronic obstructive pulmonary disease, through the recruitment, activation and survival of inflammatory cells. Lymphokines secreted from T cells regulate the pattern of inflammation, whereas proinflammatory cytokines amplify and perpetuate the inflammatory response. Multiple chemokines recruit inflammatory cells from the circulation into the lungs and many growth factors maintain this inflammation and lead to characteristic structural changes in the airways. There are several therapeutic approaches that target cytokine-mediated inflammation in chronic obstructive pulmonary disease, but blocking specific cytokines may not provide clinical benefit, whereas broad-spectrum anti-inflammatory approaches are more likely to be clinically effective.

Key Words: inflammation • cytokine • chemokine • growth factor • nuclear factor-{kappa}B


Related articles in AJRCMB:

Highlights of the December Issue
Kenneth B. Adler and Sadis Matalon
AJRCMB 2009 41: 629-630. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. B. Adler and S. Matalon
Highlights of the December Issue
Am. J. Respir. Cell Mol. Biol., December 1, 2009; 41(6): 629 - 630.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2009 American Thoracic Society.